Hyperbaric Oxygen Therapy for Long COVID

This is an honest, evidence-based guide to hyperbaric oxygen therapy (HBOT) for Long COVID — what the condition is, how HBOT might help, what the research actually shows, and the important limits. For the full picture of the therapy itself, see our main hyperbaric oxygen therapy guide.

What is Long COVID?

Long COVID (post-COVID condition) describes symptoms that persist for weeks or months after a SARS-CoV-2 infection — most commonly fatigue, “brain fog” and cognitive difficulty, breathlessness, disturbed sleep, and pain. Research increasingly links these symptoms to lingering neuroinflammation, small-vessel (microvascular) dysfunction and impaired tissue oxygen use rather than active infection.

How hyperbaric oxygen therapy works — the basics

Hyperbaric oxygen therapy (HBOT) is a medical treatment in which you breathe near-100% oxygen inside a pressurised chamber, usually around 2.0 ATA. At that pressure your blood plasma carries far more dissolved oxygen than normal — enough to reach tissue that ordinary breathing cannot. Beyond simply delivering oxygen, a course of HBOT triggers the body’s own repair signalling: it can promote the growth of new blood vessels (angiogenesis), dampen unhelpful inflammation, mobilise stem/progenitor cells and support mitochondrial energy production. These are the same, well-documented mechanisms behind HBOT’s recognised uses in wound healing and radiation injury — and they are the reason researchers have explored it in the conditions below. What matters is separating that biological plausibility from proven clinical benefit, which is exactly what this page tries to do. For the equipment itself, see our hyperbaric chamber guide.

How hyperbaric oxygen therapy may help

The rationale for HBOT in long COVID is that breathing near-100% oxygen under pressure floods plasma with oxygen, reaching hypoperfused tissue, and — through the “hyperoxic-hypoxic paradox” — can stimulate the body’s own repair signals: reduced neuroinflammation, improved microvascular function and support for mitochondrial energy production. For the underlying mechanism, see our guide on how HBOT supports brain repair.

What the research shows

Zilberman-Itskovich S, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12:11252.
In a randomised, sham-controlled trial, a course of HBOT produced measurable improvements in cognition, fatigue, sleep, psychiatric symptoms and pain compared with sham, alongside changes on brain imaging.

Robbins T, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation. Clin Med (Lond). 2021;21(6):e629-e632.
An early UK service evaluation reported improvements in fatigue and cognitive symptoms, supporting the case for larger controlled studies.

You can explore the wider evidence base in our HBOT research hub.

What the evidence cannot yet claim

• The strongest evidence is one randomised controlled trial plus early service evaluations — promising, but not yet large-scale confirmation.
• Long COVID is heterogeneous; HBOT is unlikely to help every symptom or every patient equally.
• HBOT is not an approved treatment for long COVID anywhere in the world — it should be considered, if at all, as an adjunct discussed with your doctor.

What results can you realistically expect?

Based on the current research, some patients experience meaningful improvement while others notice little change — HBOT is not a reliable or predictable treatment for Long COVID, so honest expectation-setting is part of responsible care. The most sensible mindset is a time-limited trial with clear, measured checkpoints rather than an open-ended commitment. Whatever a clinic tells you, be cautious of any promise of a guaranteed cure for Long COVID — honest, individualised assessment matters far more than marketing, and a reputable centre will happily tell you when HBOT is unlikely to help.

HBOT and your other options for Long COVID

HBOT is best understood as a possible addition to standard care, not a replacement for it. The proven foundation for Long COVID remains the treatment your specialist prescribes; HBOT is one adjunct that some patients explore when they are looking to support recovery or have not responded fully to first-line options. It should never delay or displace effective, evidence-based treatment — the safest path is to add it, if at all, with your doctor’s knowledge and a clear plan to measure whether it is actually helping.

What a course looks like

Published long-COVID protocols have used courses of around 40 sessions at ~2.0 ATA, five days a week. Any programme should be planned with clinical assessment and reviewed at a midpoint rather than committed to in full upfront. For how sessions work in practice, see how many HBOT sessions you need.

What a course of HBOT actually involves

Knowing what to expect makes the decision easier. A genuine, medical-grade course of hyperbaric oxygen therapy follows a clear pattern:

• Consultation and intake first. Before any session, a trained team should review your full medical history, current medications, imaging and goals, and design a protocol around your specific situation — not sell you a fixed package sight-unseen.
• On session day you wear comfortable cotton clothing and avoid perfumes, oils and certain cosmetics. You remove electronics and anything that could spark.
• Inside the chamber you simply rest and breathe normally. It is gently pressurised over 10–15 minutes — you feel a mild fullness in the ears, like an aircraft descent, relieved by swallowing or yawning. You then breathe oxygen at target pressure (commonly around 2.0 ATA) for 60–90 minutes.
• Decompression is slow and gentle, and there is no downtime — most people return to their day straight away.
• Review points matter: a good clinic agrees a midpoint check (often around session 20) to judge whether there is genuine, documented benefit before continuing.

For more on the practicalities, see how many sessions you need and our patient safety guide.

How to decide whether HBOT is worth considering for Long COVID

Because HBOT for Long COVID is not an approved, guaranteed treatment, the decision should be careful and doctor-led. These are the questions worth working through before you commit to a course:

• What does my treating specialist think? HBOT should sit alongside, not replace, the care they provide.
• Is the likely mechanism relevant to my case? The rationale above applies to some presentations more than others.
• Is the centre genuinely medical-grade? Insist on a PVHO-certified hard chamber and a proper clinical intake.
• How will we measure change? Agree on baseline measures and a midpoint review so any benefit is documented, not assumed.
• What is the realistic cost and time commitment? A meaningful course is multiple sessions over weeks.

Who should consider it — and important cautions

HBOT is not suitable for everyone — untreated pneumothorax, certain lung conditions, and recent ear or sinus surgery need assessment first. Because breathlessness can be part of long COVID, a proper respiratory review before starting matters. Read who should not have HBOT and is HBOT safe.

Is HBOT for Long COVID available in India?

Medical-grade hyperbaric oxygen therapy is increasingly available across India’s major cities, and HBOTLAB helps patients find a suitable centre. For Long COVID, remember this would be adjunctive, evidence-guided support — not an approved cure — so the first step is a conversation with your doctor and an honest assessment of whether it fits your case. When you are ready, our HBOT near me hub lists city guides, and our HBOT cost in India guide explains pricing. If HBOT is not right for you, we will say so plainly.

Why patients choose HBOTLAB

HBOTLAB gives honest, medical-grade guidance on hyperbaric oxygen therapy across India — PVHO-certified hard chambers, evidence-based advice rather than cure-all claims, and help finding the nearest suitable centre. If HBOT isn’t right for your situation, we’ll tell you. Find a centre near you via our HBOT near me hub.

Related reading: HBOT and cognitive recovery · Is HBOT safe?

Frequently asked questions

Can HBOT cure long COVID?

No. HBOT is not a cure or an approved treatment for long COVID. A 2022 randomised trial showed improvements in cognition, fatigue and sleep, but the evidence is still emerging and results vary between patients.

How many HBOT sessions are used for long COVID?

Published protocols used around 40 sessions at about 2.0 ATA. The right number should be decided with a clinician and reviewed partway through.

Is HBOT for long COVID available in India?

HBOT is available at medical-grade centres across India. For long COVID it would be an adjunct to your doctor’s care — contact HBOTLAB to discuss whether it is appropriate for you.

How much does HBOT for Long COVID cost in India?

HBOT is priced per session or as a package, and a course for Long COVID usually runs multiple sessions, so the total course cost is what matters. Prices depend on the chamber standard and protocol — see our HBOT cost in India guide for current, city-wise figures, and confirm a centre uses a PVHO-certified hard chamber before comparing prices.

Where can I get HBOT for Long COVID in India?

Medical-grade HBOT is available across India, though PVHO-certified hard chambers vary by clinic. For Long COVID, HBOT would be an adjunct discussed with your treating doctor first. Contact HBOTLAB and we will guide you to the nearest suitable centre and an honest view of whether it fits your situation.

Does HBOT for Long COVID hurt or have side effects?

HBOT is painless. The most common sensation is mild ear-pressure during pressurisation, like an aircraft descent, eased by swallowing or yawning. Serious side effects are uncommon at a properly run PVHO-certified centre, but HBOT is not suitable for everyone, which is why a clinical intake comes first.

How soon might I notice a difference with HBOT for Long COVID?

HBOT works cumulatively rather than after a single session, so any change tends to build over a course. Research protocols run for weeks, and a midpoint review (often around session 20) is the sensible point to judge whether it is worth continuing.